Background Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, with
a high mortality rate and poor prognosis. Mutated or dysregulated transcription factors (TFs) …

Background: Hepatocellular carcinoma (HCC) is one of the most common aggressive
malignancies with increasing incidence worldwide. The oncogenic roles of transcription …

Background Hepatocellular carcinoma (HCC) is a malignancy exhibiting the highest
lethality. The present study aimed to identify different immune-related clusters in HCC and a …

Background Hepatocellular carcinoma (HCC) has a poor prognosis and has become the
sixth most common malignancy worldwide due to its high incidence. Advanced approaches …

Background The combined application of immune cells and specific biomarkers related to
the tumor immune microenvironment has a better predictive value for the prognosis of HCC …

Simple Summary Currently, there is no effective method to detect the prognosis for
hepatocellular carcinoma (HCC). This study used bioinformatics techniques to determine …

Hepatocellular carcinoma (HCC) is a malignant lethal tumor and both cancer stem cells
(CSCs) and metabolism reprogramming have been proven to play indispensable roles in …

Background The tumor immune microenvironment is pivotal in predicting clinical outcomes
and therapeutic efficacy in cancer patients. This study aims to develop an immune prediction …

Abstract Background Liver specific genes (LSGs) are crucial for hepatocyte differentiation
and maintaining normal liver function. A deep understanding of LSGs and their …

Background: Hepatocellular carcinoma (HCC) is a common malignant tumor with high
mortality and heterogeneity. Genetic mutations caused by driver genes are important …